Trials / Withdrawn
WithdrawnNCT04593329
Efficacy and Safety of Tiradentes Association in the Treatment of Acute Pain
National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tiradentes Association in the Treatment of Acute Pain
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of Tiradentes association in adolescents and adults with acute pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TIRADENTES ASSOCIATION | Tiradentes association tablet |
| DRUG | DIPYRONE | Dipyrone 500 mg |
| DRUG | TRAMADOL | Tramadol 50 mg |
| OTHER | TIRADENTES ASSOCIATION PLACEBO | Tiradentes association placebo tablet |
| OTHER | DIPYRONE PLACEBO | Dipyrone placebo tablet |
| OTHER | TRAMADOL PLACEBO | Tramadol placebo capsule |
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2023-08-01
- Completion
- 2023-12-01
- First posted
- 2020-10-20
- Last updated
- 2023-09-08
Source: ClinicalTrials.gov record NCT04593329. Inclusion in this directory is not an endorsement.